EINDHOVEN, The Netherlands, April 27, 2026 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) will hold its annual meeting of shareholders on Wednesday, June 10, 2026 at 8:30 a.m. CET at the Company’s Headquarters, High Tech Campus 60, 5656 AG, Eindhoven, The Netherlands. NXP has filed its definitive proxy statement and annual report with the U.S. Securities and Exchange Commission and this proxy statement and other related meeting materials are also available at nxp.com/agm. NXP intends to use the notice and access proxy distribution method and expects to distribute the notice of internet availability of proxy materials no later than May 20, 2026. Shareholders may request paper copies of the proxy materials by sending a request to: NXP Semiconductors N.V., High Tech Campus 60, 5656 AG, Eindhoven, The Netherlands, Attention:...

FORT WORTH, Texas, April 27, 2026 (GLOBE NEWSWIRE) — FirstCash Holdings, Inc. (“FirstCash” or the “Company”) (Nasdaq: FCFS) today announced that the Company’s wholly-owned subsidiary, FirstCash, Inc. (the “Issuer”), has commenced an offering through a private placement, subject to market and other conditions, of $600,000,000 in aggregate principal amount of senior notes due 2034 (the “Notes”). The Notes will be unsecured senior obligations of the Issuer and will be guaranteed by FirstCash and its domestic subsidiaries that guarantee its revolving unsecured credit facility and existing senior unsecured notes. FirstCash intends to use the proceeds from the offering to repay a portion of FirstCash’s outstanding borrowings under its credit facilities in order to provide additional liquidity to fund future growth, after payment of fees...

NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) — Keel Infrastructure Corp. (NASDAQ/TSX: KEEL) (“Keel Infrastructure” or “Keel”), a North American digital and energy infrastructure company, will report its first quarter 2026 financial results on Monday, May 11 before the market opens. Management will host a conference call on the same day at 8:00 am Eastern. Q1 2026 materials will be available before the call and can be accessed on the ‘Quarterly Results’ section of the Keel investor site. The live webcast and a webcast replay of the conference call can be accessed here. To access the call by telephone, register here to receive dial-in numbers and a unique PIN to join the call. About Keel InfrastructureKeel Infrastructure is a North American digital infrastructure and energy company that develops and owns data centers and energy infrastructure...

MONACO, April 27, 2026 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE: STNG) (“Scorpio Tankers,” or the “Company”) announced today that the Company has received a commitment from Bank of America for a credit facility of up to $50 million. The credit facility will be used to finance two 2015 built LR2 product tankers, STI Rose and STI Alexis. The credit facility has a final maturity of seven years from the drawdown date of each vessel and bears interest at SOFR plus a margin of 1.20% per annum. The remaining terms and conditions of this credit facility, including financial covenants, are similar to those set forth in the Company’s existing credit facilities. The credit facility is subject to customary conditions precedent, and the execution of definitive documentation, and is expected to close within the second quarter of 2026. About...

 – Alignment reached on chemistry, manufacturing, and control (CMC) elements of ATH434 Phase 3 development program – – Positive feedback supports readiness for Phase 3 initiation with manufacturing scale-up progressing in parallel – – End-of-Phase 2 meeting with FDA remains on track for mid-2026 – MELBOURNE, Australia and SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced it has received positive regulatory feedback following a Type C Meeting with the U.S. Food and Drug Administration (FDA) regarding its planned Phase 3 development program for ATH434 in Multiple System Atrophy (MSA). MSA is a rare, rapidly progressive...